MYGN - Myriad Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2019)Next Year (2020)
No. of Analysts991010
Avg. Estimate0.40.431.751.94
Low Estimate0.360.41.711.81
High Estimate0.480.461.822.19
Year Ago EPS0.310.311.21.75
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2019)Next Year (2020)
No. of Analysts991111
Avg. Estimate216.71M216.61M864.47M928.74M
Low Estimate215.7M211.65M855.57M895.8M
High Estimate219.32M221.02M885.1M958.17M
Year Ago Sales194M193.5M772.6M864.47M
Sales Growth (year/est)11.70%11.90%11.90%7.40%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.0.240.270.330.3
EPS Actual0.310.310.380.43
Difference0.070.040.050.13
Surprise %29.20%14.80%15.20%43.30%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2019)Next Year (2020)
Current Estimate0.40.431.751.94
7 Days Ago0.40.431.751.94
30 Days Ago0.40.431.751.92
60 Days Ago0.430.461.731.98
90 Days Ago0.430.471.731.98
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1111
Up Last 30 Days3242
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesMYGNIndustrySectorS&P 500
Current Qtr.29.00%N/AN/A0.44
Next Qtr.38.70%N/AN/A0.32
Current Year45.80%N/AN/A0.21
Next Year10.90%N/AN/A0.10
Next 5 Years (per annum)11.19%N/AN/A0.12
Past 5 Years (per annum)-11.17%N/AN/AN/A